PKC-24650-63057
4 vaccinations
3 coded responses
50 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 168 / PA
- Registered
- 2021-06-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
C5F-20931-50038
Child or adolescent in my care · Male · 2022-06-25
Timeline
-
2021-06-03
Registered in v-safe
-
2021-06-03
Dose 1 — Pfizer-BioNTech
- 2021-06-03
- 2021-06-04
- 2021-06-05
- 2021-06-06
- 2021-06-07
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-17
-
2021-06-23
Dose 2 — Pfizer-BioNTech
- 2021-06-23
- 2021-06-24
- 2021-06-25
- 2021-06-26
- 2021-06-27
- 2021-06-28
- 2021-06-29
- 2021-06-30
- 2021-07-07
- 2021-07-16
- 2021-07-21
- 2021-07-28
- 2021-08-04
- 2021-09-24
- 2021-12-22
-
2021-12-23
Dose 3 — Pfizer-BioNTech
- 2021-12-24
-
2021-12-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-26
- 2021-12-27
- 2021-12-28
- 2021-12-29
- 2021-12-31
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-03-26
-
2022-06-23
Survey response — 6 months, dose 3MedDRA: Nasal congestion, Nasopharyngitis, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Nasal congestion & fever; caught a cold from my who got infected at daycare. Negative PCR for covid.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-13
Dose 4 — ModernaCo-administered: Flu
-
2022-09-16
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-09-18
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-19
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Sinus congestion — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolFree text: Sinus congestion, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Health check-in — day 7, dose 4Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
-
2022-12-13
Survey response — 3 months, dose 4MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-03 | Pfizer-BioNTech | |
| 2 | 2021-06-23 | Pfizer-BioNTech | No |
| 3 | 2021-12-23 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Moderna | Flu |
Free text
Release 12 — 6 months, dose 3
Symptoms: Nasal congestion & fever; caught a cold from my who got infected at daycare. Negative PCR for covid.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Sinus congestion, cough
Release 12 — 3 months, dose 4
Symptoms: Runny nose, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release